| 2026-04-01 | ai-drug-discovery | Artificial Intelligence-Driven Natural Product Discovery for Cancer Metastasis and Chemoresistance: From Computational Prediction to Preclinical Validation. | Cancers | 57.9 | PMID, DOI |
| 2026-04-01 | ai-drug-discovery | Drug repurposing in oncology: Bridging computational discovery to clinical application. | International journal of cancer | 56.3 | PMID, DOI |
| 2026-04-01 | ai-drug-discovery | OptiSyn: an interpretable, multi-omics-driven graph convolutional network framework for synergy-oriented drug combination design in disease treatment. | Chinese medicine | 54.7 | PMID, DOI |
| 2026-04-01 | de-novo-protein-design | Semantic design of functional de novo genes from a genomic language model. | Nature | 69.1 | PMID, DOI |
| 2026-04-01 | de-novo-protein-design | Computational design of metallohydrolases. | Nature | 68.0 | PMID, DOI |
| 2026-04-01 | de-novo-protein-design | Computational enzyme design by catalytic motif scaffolding. | Nature | 65.9 | PMID, DOI |
| 2026-04-02 | ai-drug-discovery | Towards intelligent and miniaturized drug delivery devices. | Nature | 57.9 | PMID, DOI |
| 2026-04-06 | ai-drug-discovery | Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review. | Renal failure | 54.5 | PMID, DOI |
| 2026-04-07 | ai-drug-discovery | Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes. | Cell | 53.0 | PMID, DOI |
| 2026-04-08 | ai-drug-discovery | An international mega-analysis of psychedelic drug effects on brain circuit function. | Nature medicine | 56.5 | PMID, DOI |
| 2026-04-15 | ai-drug-discovery | A Comparative Review of Artificial Intelligence Applications in Small Molecule Versus Peptide Drug Discovery. | International journal of molecular sciences | 59.8 | PMID, DOI |
| 2026-04-16 | ai-drug-discovery | Stem Cell-Derived Organoids for Cancer Therapy: Precision Medicine and Drug Selection. | International journal of molecular sciences | 54.5 | PMID, DOI |
| 2026-04-18 | ai-drug-discovery | A review on AI-enabled drug design in medicinal chemistry: Analytical validation, challenges, and regulatory considerations. | Talanta | 54.7 | PMID, DOI |
| 2026-04-24 | ai-drug-discovery | AI/ML in drug product development & manufacturing - report on the 8th APV Winter conference. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 54.7 | PMID, DOI |
| 2026-04-25 | ai-drug-discovery | Artificial intelligence driven innovation in tuberculosis drug discovery. | The Indian journal of tuberculosis | 59.8 | PMID, DOI |
| 2026-04-28 | ai-drug-discovery | From Prompt to Drug: Toward Pharmaceutical Superintelligence. | ACS central science | 58.7 | PMID, DOI |